DoW Alzheimer’s Transforming Care Award

The fiscal year 2026 Alzheimer’s Research Program Transforming Care Award (HT942526AZRPTrCA) is a funding opportunity issued by the Defense Health Agency to support clinical research and trials focused on dementia care for individuals with Alzheimer’s disease and related dementias (AD/ADRD) and their care partners. The program prioritizes solution-oriented research that informs improvements in long-term care, psychosocial wellness, and quality of life, with a specific emphasis on aging in place and the unique needs of Service Members, Veterans, and their families. While clinical trials are permitted, those solely evaluating pharmacological interventions or utilizing animal models are not allowed. Applicants must provide preliminary data and a community collaboration plan for research involving human subjects. The program has a total allotment of approximately 5.4 million dollars to fund about three awards, with a maximum period of performance of four years. Funding is capped at 1.6 million dollars for the single PI option and 1.9 million dollars combined for the Career Initiation or Transition (CIT) Partnership Option. The application process is a two-step submission requiring a pre-application by June 22, 2026, and a full application by September 24, 2026, via eBRAP or Grants.gov. Evaluation is based on a two-tier review process focusing on impact, research strategy and feasibility, and recruitment plans, while also considering the budget, environment, and research sharing plans as unscored criteria. All applicant organizations must maintain active registration in SAM.gov, eBRAP.org, and Grants.gov and disclose all foreign affiliations of key personnel.